Moreover, reduced levels of Beclin 1 protein have been correlated to poor patient outcome in many tumor types, such as esophageal cancer [10], stage III colon cancer [11], hepatocellular carcinoma [12] and high-grade glioma [13]. Here, BECN1 is linked to malignant colon neoplasm.